Impact of Obesity and Body Fat Distribution on Survival After Pancreaticoduodenectomy for Pancreatic Adenocarcinoma

[1]  Michael J Thun,et al.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. , 2003, The New England journal of medicine.

[2]  B. Goodpaster.  Measuring body fat distribution and content in humans , 2002, Current opinion in clinical nutrition and metabolic care.

[3]  N. Abate.  Insulin Resistance and Obesity: The role of fat distribution pattern , 1996, Diabetes Care.

[4]  A. Walch,et al.  Inflammation and mitochondrial fatty acid β-oxidation link obesity to early tumor promotion , 2009, Proceedings of the National Academy of Sciences.

[5]  H. Pitt,et al.  Obesity potentiates the growth and dissemination of pancreatic cancer. , 2009, Surgery.

[6]  Wei Zheng,et al.  Anthropometric measures, body mass index, and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan). , 2010, Archives of internal medicine.

[7]  H. Pitt,et al.  Insulin, Leptin, and Tumoral Adipocytes Promote Murine Pancreatic Cancer Growth , 2010, Journal of Gastrointestinal Surgery.

[8]  F. Clavel-Chapelon,et al.  Anthropometry, Physical Activity, and the Risk of Pancreatic Cancer in the European Prospective Investigation into Cancer and Nutrition , 2006, Cancer Epidemiology Biomarkers & Prevention.

[9]  A. Wirth,et al.  Gender differences in changes in subcutaneous and intra-abdominal fat during weight reduction: an ultrasound study. , 1998, Obesity research.

[10]  M. Gonen,et al.  Preoperative Predictors for Complications after Pancreaticoduodenectomy: Impact of BMI and Body Fat Distribution , 2007, Journal of Gastrointestinal Surgery.

[11]  N. Petersen,et al.  Intra-abdominal Fat Predicts Survival in Pancreatic Cancer , 2010, Journal of Gastrointestinal Surgery.

[12]  E. Calle,et al.  Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms , 2004, Nature Reviews Cancer.

[13]  Robert C. G. Martin,et al.  Body Mass Index and Outcomes from Pancreatic Resection: a Review and Meta-analysis , 2011, Journal of Gastrointestinal Surgery.

[14]  R. Ross,et al.  Influence of sex on total and regional fat loss in overweight and obese men and women , 2009, International Journal of Obesity.

[15]  G. Klöppel,et al.  Course of alcoholic chronic pancreatitis: a prospective clinicomorphological long-term study. , 1996, Gastroenterology.

[16]  M. Woodward,et al.  The Effect of Modifiable Risk Factors on Pancreatic Cancer Mortality in Populations of the Asia-Pacific Region , 2006, Cancer Epidemiology Biomarkers & Prevention.

[17]  M. Choti,et al.  Impact of Obesity on Perioperative Outcomes and Survival Following Pancreaticoduodenectomy for Pancreatic Cancer: A Large Single-Institution Study , 2010, Journal of Gastrointestinal Surgery.

[18]  Heidi M. Blanck,et al.  Vital signs: state-specific obesity prevalence among adults --- United States, 2009. , 2010, MMWR. Morbidity and mortality weekly report.

[19]  M. Gonen,et al.  Allergies, obesity, other risk factors and survival from pancreatic cancer , 2010, International journal of cancer.

[20]  J. Donohue,et al.  Does Body Mass Index/Morbid Obesity Influence Outcome in Patients Who Undergo Pancreatoduodenectomy for Pancreatic Adenocarcinoma? , 2010, Journal of Gastrointestinal Surgery.

[21]  W. Bamlet,et al.  Obesity adversely affects survival in pancreatic cancer patients , 2010, Cancer.

[22]  W. Hawkins,et al.  Influence of Obesity and Other Risk Factors on Survival Outcomes in Patients Undergoing Pancreaticoduodenectomy for Pancreatic Cancer , 2011, Pancreas.

[23]  K. McMasters,et al.  The Impact of Obesity on Outcomes Following Pancreatectomy for Malignancy , 2009, Annals of Surgical Oncology.

[24]  G. Hunter,et al.  Body fat distribution in white and black women: different patterns of intraabdominal and subcutaneous abdominal adipose tissue utilization with weight loss. , 2001, The American journal of clinical nutrition.

[25]  A. Sauvanet,et al.  Fatty pancreas and increased body mass index are risk factors of pancreatic fistula after pancreaticoduodenectomy. , 2010, Surgery.

[26]  P. Allen,et al.  Defining morbidity after pancreaticoduodenectomy: use of a prospective complication grading system. , 2007, Journal of the American College of Surgeons.

[27]  Udo Hoffmann,et al.  Abdominal Visceral and Subcutaneous Adipose Tissue Compartments: Association With Metabolic Risk Factors in the Framingham Heart Study , 2007, Circulation.

[28]  P. A. van den Brandt,et al.  A pooled analysis of 14 cohort studies of anthropometric factors and pancreatic cancer risk , 2011, International journal of cancer.

[29]  D. Sellen,et al.  Genetics of Criminal and Antisocial Behaviour. Ciba Foundation Symposium 194. Pp. 283. Edited by G. R. Bock & J. A. Goode. (Wiley, Chichester, 1996.) £50.00. , 1998, Journal of Biosocial Science.

[30]  Jeffrey S. Morris,et al.  Influence of obesity on cancer-related outcomes after pancreatectomy to treat pancreatic adenocarcinoma. , 2009, Archives of surgery.

[31]  K. Lillemoe,et al.  Pancreatic steatosis promotes dissemination and lethality of pancreatic cancer. , 2009, Journal of the American College of Surgeons.

[32]  Franck Bonnetain,et al.  Visceral fat area is an independent predictive biomarker of outcome after first-line bevacizumab-based treatment in metastatic colorectal cancer , 2009, Gut.

[33]  T. Keck,et al.  The Lymph Node Ratio is the Strongest Prognostic Factor after Resection of Pancreatic Cancer , 2009, Journal of Gastrointestinal Surgery.

[34]  B. Gersh.  National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants , 2012 .

[35]  J. Murabito,et al.  Visceral and Subcutaneous Adipose Tissue Volumes Are Cross-Sectionally Related to Markers of Inflammation and Oxidative Stress: The Framingham Heart Study , 2007, Circulation.

[36]  Shumei S. Sun,et al.  Visceral adiposity and its anatomical distribution as predictors of the metabolic syndrome and cardiometabolic risk factor levels. , 2008, The American journal of clinical nutrition.

[37]  S. Larsson,et al.  Body mass index and pancreatic cancer risk: A meta‐analysis of prospective studies , 2007, International journal of cancer.

[38]  P. Kant,et al.  Excess body weight and obesity—the link with gastrointestinal and hepatobiliary cancer , 2011, Nature Reviews Gastroenterology &Hepatology.

[39]  J. Barkin.  Overall obesity, abdominal adiposity, diabetes and cigarette smoking in relation to the risk of pancreatic cancer in two Swedish population-based cohorts , 2008 .

[40]  Jonathan Hernandez,et al.  Preoperative computed tomography measurements of pancreatic steatosis and visceral fat: prognostic markers for dissemination and lethality of pancreatic adenocarcinoma. , 2011, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[41]  J. Dixon,et al.  Factors associated with percent change in visceral versus subcutaneous abdominal fat during weight loss: findings from a systematic review , 2008, International Journal of Obesity.

[42]  Jeffrey S. Morris,et al.  Body Mass Index and Risk , Age of Onset , and Survival in Patients With Pancreatic Cancer , 2009 .